145 related articles for article (PubMed ID: 32487848)
41. [Iron overload in sickle cell anemia : a study of 94 patients].
Hafsia R; Belakhal F; Ben Salah N; Gouider E; Elborgi W
Tunis Med; 2011 Jun; 89(6):548-52. PubMed ID: 21681718
[TBL] [Abstract][Full Text] [Related]
42. Red blood cell transfusion support and management of secondary iron overload in patients with haematological malignancies in the Netherlands: a survey.
Hoeks MPA; Middelburg RA; Romeijn B; Blijlevens NMA; van Kraaij MGJ; Zwaginga JJ
Vox Sang; 2018 Feb; 113(2):152-159. PubMed ID: 29266372
[TBL] [Abstract][Full Text] [Related]
43. Cytomegalovirus Reactivation after Allogeneic Hematopoietic Stem Cell Transplantation is Associated with a Reduced Risk of Relapse in Patients with Acute Myeloid Leukemia Who Survived to Day 100 after Transplantation: The Japan Society for Hematopoietic Cell Transplantation Transplantation-related Complication Working Group.
Takenaka K; Nishida T; Asano-Mori Y; Oshima K; Ohashi K; Mori T; Kanamori H; Miyamura K; Kato C; Kobayashi N; Uchida N; Nakamae H; Ichinohe T; Morishima Y; Suzuki R; Yamaguchi T; Fukuda T
Biol Blood Marrow Transplant; 2015 Nov; 21(11):2008-16. PubMed ID: 26211985
[TBL] [Abstract][Full Text] [Related]
44. Trends in transfusion burden among long-term survivors of childhood hematological malignancies.
Nottage K; Gurney JG; Smeltzer M; Castellanos M; Hudson MM; Hankins JS
Leuk Lymphoma; 2013 Aug; 54(8):1719-23. PubMed ID: 23163568
[TBL] [Abstract][Full Text] [Related]
45. Transfusion intensity, not the cumulative red blood cell transfusion burden, determines the prognosis of patients with myelodysplastic syndrome on chronic transfusion support.
Pereira A; Nomdedeu M; Aguilar JL; Belkaid M; Carrió A; Cobo F; Costa D; Rozman M; Sanz C; Nomdedeu B
Am J Hematol; 2011 Mar; 86(3):245-50. PubMed ID: 21328437
[TBL] [Abstract][Full Text] [Related]
46. Transfusional iron overload in heavily transfused patients: Real-life data from a 10-year retrospective study of 611 cases managed in a French general hospital.
Bauduer F; Recanzone H
Transfus Clin Biol; 2022 Aug; 29(3):236-242. PubMed ID: 35476962
[TBL] [Abstract][Full Text] [Related]
47. Cardiac iron overload in transfusion-dependent patients with myelodysplastic syndromes.
Roy NB; Myerson S; Schuh AH; Bignell P; Patel R; Wainscoat JS; McGowan S; Marchi E; Atoyebi W; Littlewood T; Chacko J; Vyas P; Killick SB
Br J Haematol; 2011 Aug; 154(4):521-4. PubMed ID: 21689086
[TBL] [Abstract][Full Text] [Related]
48. An assessment of iron overload in children treated for cancer and nonmalignant hematologic disorders.
Rascon J; Rageliene L; Stankeviciene S; Palionis D; Tamosiunas AE; Valeviciene N; Zvirblis T
Eur J Pediatr; 2014 Sep; 173(9):1137-46. PubMed ID: 24659311
[TBL] [Abstract][Full Text] [Related]
49. Lifetime Transfusion Burden and Transfusion-Related Iron Overload in Adult Survivors of Solid Malignancies.
Woei-A-Jin FJSH; Zheng SZ; Kiliçsoy I; Hudig F; Luelmo SAC; Kroep JR; Lamb HJ; Osanto S
Oncologist; 2020 Feb; 25(2):e341-e350. PubMed ID: 32043782
[TBL] [Abstract][Full Text] [Related]
50. Reducing the red blood cell transfusion threshold from 8·0 g/dl to 7·0 g/dl in acute myeloid leukaemia patients undergoing induction chemotherapy reduces transfusion rates without adversely affecting patient outcome.
Ballo O; Fleckenstein P; Eladly F; Kreisel EM; Stratmann J; Seifried E; Müller M; Serve H; Bug G; Bonig H; Brandts CH; Finkelmeier F
Vox Sang; 2020 Oct; 115(7):570-578. PubMed ID: 32342521
[TBL] [Abstract][Full Text] [Related]
51. Iron overload in hematopoietic cell transplantation.
Majhail NS; Lazarus HM; Burns LJ
Bone Marrow Transplant; 2008 Jun; 41(12):997-1003. PubMed ID: 18438425
[TBL] [Abstract][Full Text] [Related]
52. Outcomes in RBC transfusion-dependent patients with Low-/Intermediate-1-risk myelodysplastic syndromes with isolated deletion 5q treated with lenalidomide: a subset analysis from the MDS-004 study.
Giagounidis A; Mufti GJ; Mittelman M; Sanz G; Platzbecker U; Muus P; Selleslag D; Beyne-Rauzy O; te Boekhorst P; del Cañizo C; Guerci-Bresler A; Nilsson L; Lübbert M; Quesnel B; Ganser A; Bowen D; Schlegelberger B; Göhring G; Fu T; Benettaib B; Hellström-Lindberg E; Fenaux P
Eur J Haematol; 2014 Nov; 93(5):429-38. PubMed ID: 24813620
[TBL] [Abstract][Full Text] [Related]
53. Impact of performance status and transfusion dependency on outcome of patients with myelodysplastic syndrome, acute myeloid leukemia and chronic myelomonocytic leukemia treated with azacitidine (PIAZA study).
Wehmeyer J; Zaiss M; Losem C; Schmitz S; Niemeier B; Harde J; Hannig CV; Harich HD; Müller J; Klausmann M; Tessen HW; Potthoff K
Eur J Haematol; 2018 Dec; 101(6):766-773. PubMed ID: 30091166
[TBL] [Abstract][Full Text] [Related]
54. Prognostic impact of pre-transplantation transfusion history and secondary iron overload in patients with myelodysplastic syndrome undergoing allogeneic stem cell transplantation: a GITMO study.
Alessandrino EP; Della Porta MG; Bacigalupo A; Malcovati L; Angelucci E; Van Lint MT; Falda M; Onida F; Bernardi M; Guidi S; Lucarelli B; Rambaldi A; Cerretti R; Marenco P; Pioltelli P; Pascutto C; Oneto R; Pirolini L; Fanin R; Bosi A
Haematologica; 2010 Mar; 95(3):476-84. PubMed ID: 19903678
[TBL] [Abstract][Full Text] [Related]
55. Impact of transfusion dependency and secondary iron overload on the survival of patients with myelodysplastic syndromes.
Malcovati L
Leuk Res; 2007 Dec; 31 Suppl 3():S2-6. PubMed ID: 18037415
[TBL] [Abstract][Full Text] [Related]
56. [Transfusions in myelodysplastic syndromes].
Rose C
Transfus Clin Biol; 2017 Sep; 24(3):209-215. PubMed ID: 28651884
[TBL] [Abstract][Full Text] [Related]
57. Red blood cell transfusion burden in myelodysplastic syndromes (MDS) with ring Sideroblasts (RS): A retrospective multicenter study by the Groupe Francophone des Myélodysplasies (GFM).
Jouzier C; Cherait A; Cony-Makhoul P; Hamel JF; Veloso M; Thepot S; Cluzeau T; Stamatoullas A; Garnier A; Guerci-Bresler A; Dimicoli-Salazar S; Pica GM; Cheze S; Santana C; Chermat F; Fenaux P; Park S
Transfusion; 2022 May; 62(5):961-973. PubMed ID: 35452143
[TBL] [Abstract][Full Text] [Related]
58. Impact of iron overload and potential benefit from iron chelation in low-risk myelodysplastic syndrome.
Shenoy N; Vallumsetla N; Rachmilewitz E; Verma A; Ginzburg Y
Blood; 2014 Aug; 124(6):873-81. PubMed ID: 24923296
[TBL] [Abstract][Full Text] [Related]
59. Iron overload after allogeneic stem cell transplantation in children with acute lymphoblastic leukemia.
Salmi A; Holmström M; Toiviainen-Salo S; Kanerva J; Taskinen M
Pediatr Transplant; 2020 Dec; 24(8):e13846. PubMed ID: 33111465
[TBL] [Abstract][Full Text] [Related]
60. Evaluation and treatment of transfusional iron overload in children.
Ware HM; Kwiatkowski JL
Pediatr Clin North Am; 2013 Dec; 60(6):1393-406. PubMed ID: 24237978
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
